Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genekam Biotechnology is a German biotechnology company specializing in the development and manufacture of advanced molecular diagnostic solutions, particularly PCR-based kits for detecting a wide range of pathogens. The company provides tools for identifying viruses, bacteria, and parasites, including high-profile targets like SARS-CoV-2, Influenza, and Zika. Beyond diagnostics, Genekam is active in stem cell research and the development of specialized cell culture media. Their product portfolio serves clinical laboratories, research institutions, and the agricultural sector globally. The company is headquartered in Duisburg and emphasizes rapid, cost-effective molecular testing. Genekam also offers specialized reagents and DNA/RNA extraction kits to support various molecular biology workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genekam Biotechnology.